Antibody Discovery News and Research

RSS
Researchers find plasma donors with broad malaria protection

Researchers find plasma donors with broad malaria protection

New microchip tracks antibody-virus interactions from a single drop of blood

New microchip tracks antibody-virus interactions from a single drop of blood

Vanderbilt and Parse Biosciences team up to develop antibody treatments for measles

Vanderbilt and Parse Biosciences team up to develop antibody treatments for measles

Scaling B-cell cloning workflows for antibody development

Scaling B-cell cloning workflows for antibody development

Sphere Bio expands operations in China

Sphere Bio expands operations in China

New antibody discovery reveals powerful immune defense against tuberculosis

New antibody discovery reveals powerful immune defense against tuberculosis

Sapio Sciences appoints Gordon McCall as Chief Operating Officer to drive global operational excellence

Sapio Sciences appoints Gordon McCall as Chief Operating Officer to drive global operational excellence

Unlocking live single-cell functional insights

Unlocking live single-cell functional insights

Scientists use AI to build mutation-proof antibodies for SARS-CoV-2

Scientists use AI to build mutation-proof antibodies for SARS-CoV-2

Sapio Sciences introduces Biorepository Management solution in Sapio Release 25.4

Sapio Sciences introduces Biorepository Management solution in Sapio Release 25.4

Bruker to launch Beacon Discovery™ at AACR 2025, expanding access to live single-cell functional analysis

Bruker to launch Beacon Discovery™ at AACR 2025, expanding access to live single-cell functional analysis

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

Fairjourney Biologics acquires Charles River Laboratories South San Francisco facility

Fairjourney Biologics acquires Charles River Laboratories South San Francisco facility

New human antibody shows promise for Ebola virus treatment

New human antibody shows promise for Ebola virus treatment

Harbour BioMed partners with Insilico to accelerate AI-powered antibody discovery

Harbour BioMed partners with Insilico to accelerate AI-powered antibody discovery

Sapio Sciences Expands Leadership Team to Drive Growth

Sapio Sciences Expands Leadership Team to Drive Growth

Schrödinger selects Sapio Sciences to enhance in silico drug discovery from plasmid to structure

Schrödinger selects Sapio Sciences to enhance in silico drug discovery from plasmid to structure

Trilobio introduces whole-laboratory automation platform at SLAS2025

Trilobio introduces whole-laboratory automation platform at SLAS2025

Sphere Fluidics launches Cyto-Mine Chroma and announces Early Access Program

Sphere Fluidics launches Cyto-Mine Chroma and announces Early Access Program

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.